Suppr超能文献

骨保护素/肿瘤坏死因子相关凋亡诱导配体比值作为急性 A 型主动脉夹层患者死亡率的预测生物标志物。

OPG/TRAIL ratio as a predictive biomarker of mortality in patients with type A acute aortic dissection.

机构信息

Beijing Anzhen Hospital of Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.

Xi Jing Hospital of Fourth Military Medical University, Xian, China.

出版信息

Nat Commun. 2021 Jun 7;12(1):3401. doi: 10.1038/s41467-021-23787-5.

Abstract

Following hospital discharge, patients with type A acute aortic dissection (TA-AAD) may present an increase in mortality risk. However, little is known about specific biomarkers associated with post-discharge survival, and there is a paucity of prognostic markers associated with TA-AAD. Here, we identify nine candidate proteins specific for patietns with TA-AAD in a cross-sectional dataset by unbiased protein screening and in-depth bioinformatic analyses. In addition, we explore their association with short-term and long-term mortality in a derivation cohort of patients with TA-AAD, including an internal (n = 300) and external (n = 236) dataset. An elevated osteoprotegerin (OPG)/tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) ratio was the strongest predictor of overall, 30-day, post-30-day mortality in both datasets and was confirmed to be a strong predictor of mortality in an independent validation cohort (n = 400). Based on OPG/TRAIL ratio-guided risk stratification, patients at high risk (>33) had a higher 1-year mortality (55.6% vs. 4.3%; 68.2% vs. 2.6%) than patients at low risk (<4) in both cohorts. In Conclusion, we show that an elevated OPG/TRAIL ratio is associated with a significant increase in short-term and long-term mortality in patients with TA-AAD.

摘要

在医院出院后,A型急性主动脉夹层(TA-AAD)患者的死亡率可能会增加。然而,目前对于与出院后生存相关的特定生物标志物知之甚少,并且与 TA-AAD 相关的预后标志物也很少。在这里,我们通过无偏蛋白筛选和深入的生物信息学分析,在横断面数据集确定了 9 种与 TA-AAD 患者相关的候选蛋白。此外,我们还在 TA-AAD 患者的推导队列中探索了它们与短期和长期死亡率的关系,包括内部(n=300)和外部(n=236)数据集。骨保护素(OPG)/肿瘤坏死因子相关凋亡诱导配体(TRAIL)比值升高是两个数据集总死亡率、30 天死亡率和 30 天后死亡率的最强预测指标,并在独立验证队列(n=400)中被证实是死亡率的强有力预测指标。基于 OPG/TRAIL 比值指导的风险分层,高风险(>33)患者的 1 年死亡率(55.6% vs. 4.3%;68.2% vs. 2.6%)明显高于低风险(<4)患者(均 P<0.001)。总之,我们表明,OPG/TRAIL 比值升高与 TA-AAD 患者短期和长期死亡率显著增加相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验